156 related articles for article (PubMed ID: 12556703)
1. Resolution of azole-resistant oesophageal candidiasis in an AIDS patient after treatment with caspofungin.
Smith K; Youle M; Baker B; Ballinger J; Cuthbertson Z; Johnson M
AIDS; 2003 Feb; 17(3):448-9. PubMed ID: 12556703
[No Abstract] [Full Text] [Related]
2. Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin.
Sollima S; Corbellino M; Cicconi P; Piazza M; Viganò O; Antinori S
AIDS; 2002 Jun; 16(9):1303-4. PubMed ID: 12045503
[No Abstract] [Full Text] [Related]
3. Caspofungin in the treatment of oropharyngeal candidiasis.
Garbino J; Lew D; Hirschel B; Rohner P
Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.
Kartsonis N; DiNubile MJ; Bartizal K; Hicks PS; Ryan D; Sable CA
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):183-7. PubMed ID: 12394797
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
[TBL] [Abstract][Full Text] [Related]
6. Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin.
Dinubile MJ; Lupinacci RJ; Berman RS; Sable CA
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):903-8. PubMed ID: 12230933
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.
Arathoon EG; Gotuzzo E; Noriega LM; Berman RS; DiNubile MJ; Sable CA
Antimicrob Agents Chemother; 2002 Feb; 46(2):451-7. PubMed ID: 11796357
[TBL] [Abstract][Full Text] [Related]
8. Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them.
Darouiche RO
Clin Infect Dis; 2004 Sep; 39(6):850-2. PubMed ID: 15472818
[No Abstract] [Full Text] [Related]
9. Posaconazole for azole-refractory candidiasis in patients with HIV infection.
Winslow DL
AIDS Alert; 2007 May; 22(5):59-60. PubMed ID: 17577961
[No Abstract] [Full Text] [Related]
10. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin versus amphotericin B for invasive candidiasis.
Brown AL; Greig JR
N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
[No Abstract] [Full Text] [Related]
12. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
Sorà F; Chiusolo P; Piccirillo N; Pagano L; Laurenti L; Farina G; Sica S; Leone G
Clin Infect Dis; 2002 Nov; 35(9):1135-6. PubMed ID: 12384850
[No Abstract] [Full Text] [Related]
13. Caspofungin--a new therapeutic option for oropharyngeal candidiasis.
Garbino J
Clin Microbiol Infect; 2004 Mar; 10(3):187-9. PubMed ID: 15008939
[TBL] [Abstract][Full Text] [Related]
14. Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug.
J Assoc Nurses AIDS Care; 2001; 12(4):93-4. PubMed ID: 11486726
[No Abstract] [Full Text] [Related]
15. Caspofungin.
Deresinski SC; Stevens DA
Clin Infect Dis; 2003 Jun; 36(11):1445-57. PubMed ID: 12766841
[TBL] [Abstract][Full Text] [Related]
16. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.
Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J
J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
[TBL] [Abstract][Full Text] [Related]
18. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin-resistant oral and esophageal candidiasis in a patient with AIDS.
Jokela JA; Kaur P
AIDS; 2007 Jan; 21(1):118-9. PubMed ID: 17148982
[No Abstract] [Full Text] [Related]
20. A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
Vazquez JA; Schranz JA; Clark K; Goldstein BP; Reboli A; Fichtenbaum C
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):304-9. PubMed ID: 18545153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
